Preparation, characterization, therapeutic efficacy and toxicity of liposomes, containing the antitumour drug cis-dichlorodiamineplatinum(II)

References

• Allen T. M., McAllister L., Mausolf S., Gyorffy E. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anticancer drug with the EMT6, S49 and AE1 (transport-deficient) cell lines. Biochimica et Biophysica Acta 1981; 643: 346–362
   PubMed Web of Science ®Google Scholar
• Arndt D., Fichtner I., Reszka R., Elbe B. Darstellung, Eigenschaften und therapeutische Wirksamkeit von daunorubicinhaltigen Liposomen. Pharmazie 1983; 38: 331–335
   PubMedGoogle Scholar
• Burchenal H., Lokys L., Turkevich J., Gale G. Rationale of combination chemotherapy. Cisplatin, Current Status and New Developments, A. W. Prestayko, T. Crooke, St, K. Carter, St. Academic Press, New York 1980; 113–121
   Google Scholar
• Cancer and Chemotherapy, III. Antineoplastic Agents, T. Crooke, St, A. W. Prestayko. Academic Press, New York, London, Toronto, Sydney, San Francisco 1981; 1–389
   Google Scholar
• Forge A., Knowtes P. F., Marsh D. Morphology of egg phosphatidylcholine-cholesterol-single-bilayer vesicle studies by freeze etch electron microscopy. Journal of Membrane Biology 1978; 41: 249–263
   PubMedGoogle Scholar
• Freise J., Müller W. H., Magerstedt P., Schmoll H. J. Pharmacokinetics of liposome encapsulated cisplatin in rats. Archives of Internal Pharmacodynamic Therapy 1982; 258: 180–192
   PubMedGoogle Scholar
• Liposomes in Biological Systems, G. Gregoriades, A. C. Allison. John Wiley and Sons, Chichester, New York, Brisbane, Toronto 1980; 1–399
   Google Scholar
• Liposome Technology I-III, G. Gregoriades. CRC Press, Inc, Boca Raton, Florida 1984; 1–283
   Google Scholar
• Hall L. M., Ridgway H. J., Speer R. J., Newman A. D., Stewart D. P. Thin layer chromatography of platinum coordination compounds. Journal of Clinical Haematology and Oncology 1980; 10: 29–34
   Google Scholar
• Hickman J. A., Scanlon K. J., Tritton T. R. Membrane targets in cancer chemotherapy. Trends in Pharmacological Science 1984; 5: 15–17
   Google Scholar
• Hong K., Fried D. S., Glabe Ch. G., Papahadjopoulos D. Liposomes containing colloidal gold are a useful probe of liposomecell interactions. Biochimica et Biophysica Acta 1983; 732: 320–323
   PubMed Web of Science ®Google Scholar
• Horn G. Polarographische Bestimmung von cis-Dichlorodiammin-Platin(II). Pharmazie 1984; 39: 715–716
   Google Scholar
• Juliano R. L., Stamp D. Pharmacokinetics of liposome-encapsulated antitumor drugs. Biochemistry and Pharmacology 1978; 27: 21–27
   PubMed Web of Science ®Google Scholar
• Liposomes as drug delivery systems. Drug Delivery Systems, R. L. Juliano, D. Layton. Oxford University Press, Oxford 1980
   Google Scholar
• Kaledin V. I., Matienko N. A., Nikolin V. P., Srutenko Y. V., Budker V. K. Intralymphatic administration of liposome-encapsulated drugs to mice: Possibility for suppression of the growth or tumor metastases in the lymph nodes. Journal of the National Cancer Institute 1981; 66: 881–887
   PubMedGoogle Scholar
• Liposomes: From Physical Structure to Therapeutic Applications, C. G. Knight. Elsevier/North-Holland Biomedical Press, Amsterdam 1981; 1–487
   Google Scholar
• Ladhoff A.-M., Koelsch R., Lasch J. Incorporation of chemically modified (hydrophobized) ferritin in liposomal membranes: Electron microscopic studies. Biomedica et Biochirnica Acta 1984; 43: 963–969
   PubMedGoogle Scholar
• Le: Roy A. F., Wehling M. L., Sponseller H. C. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochemical Medicine 1977; 18: 184–191
   PubMed Web of Science ®Google Scholar
• Loetner P. J., Einhorn L. M. Cisplatin. Annals of Internal Medicine 1984; 100: 704–794
   PubMedGoogle Scholar
• Makita T., Itagaki S., Ohokawa T. X-ray microanalysis and ultrastructural localization of cisplatin in liver and kidney of the rat. Japanese Journal of Cancer Research (GANN) 1985; 76: 895–901
   PubMedGoogle Scholar
• Musja G. I., Barsukov L. I., Gorkowa N. P., Sorokina I. P., Pirusjan L. A., Bergelson L. D., Moschlowski J. S. Antitumorale und toxische Eigenschaften von Phospholipidvesikeln, die cis-Dichlorodiaminplatin enthalten. Bulletin of Experimental Biology and Medicine 1981; 92: 590–593
   Google Scholar
• Nissen E., Arnold W., Weis M., Tanneberger, St. Biological characterization of human mesothelioma line in the nude mice. II. Some characteristics of cells cultivated in vitro prior to and after transplantation in the nude mice. Archiv Geschwulstforschung 1979; 49: 544–550
   PubMedGoogle Scholar
• Cisplatin, A. W. Prestayko, T. Crooke, St, G. K. Carter. Academic Press, New York 1980
   Google Scholar
• Reishus I. W., Martin D. S. Cis-dichlorodiamine-platinum(II). Acid hydrolysis and isotopic exchange of the chloride ligands. Journal of the American Chemical Society 1961; 83: 2475
   Google Scholar
• Reszka R. Thesis. AdW der DDR 1986
   Google Scholar
• Reszka R., Arndt D., Fichtner I., Nissen E., Elbe B., Jandrig J., Hentschel M. Characterization, in vitro cytoxicity, therapeutic efficacy and cardiotoxicity of adaunorubicin encapsulated in liposomes. Studia biophysika 1984; 104: 233–245
   Google Scholar
• Wiley C. M., Sternson L. A. Cisplatin. Analytical Profiles of Drug Substances 1985; 14: 78–101
   Google Scholar
• Roberts J. J. Cisplatin. Cancer Chemotherapy, H. H. Pinedo, B. A. Chabner. Elsevier, Amsterdam, New York, Oxford 1983; 1–502
   Google Scholar
• Rosenberg B. Possible mechanisms of action of platinum anticancer drugs. Thirteenth Chemotherapy Congress, Vienna, 1983
   Google Scholar
• Sur B., Ray R. R., Sur P., Roy D. K. Effect of liposomal encapsulation of cis-platinum diaminedichloride in the treatment of Ehrlich ascites carcinoma. Oncology 1983; 40: 372–376
   PubMedGoogle Scholar
• Szoka F., Papahadjopoulos D. Liposomes: Preparation and characterization 51–77. Liposomes: From Physical Structure to Therapeutic Applications, C. G. Knight. Elsevier/North-Holland Biomedical Press, Amsterdam 1981
   Google Scholar
• Walker E. M., Gate G. R. Methods of reduction of cisplatin nephrotoxicity. Annals of Clinical Laboratory Science 1981; 11: 397–410
   PubMedGoogle Scholar
• Yatvin M. B., Mühlensiepen H., Porschen W., Weinstein I. N., Feinendegen L. E. Selective delivery of liposome-associated cis-dichlorodiamineplatinum (II) by heat and its influence on tumor drug uptake and growth. Cancer Research 1981; 41: 1602–1607
   PubMed Web of Science ®Google Scholar
• Yoshioka S., Ishibashi M., Shibazaki T., Uchiyama M. Plasma-induced instability of reverse-phase evaporation vesicles. Journal of Parenteral Science and Technology 1984; 38: 222–227
   PubMedGoogle Scholar